4166.TWO
Price:
$32.45
Market Cap:
$7.24B
Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4166.TWO
According to Orient Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 60.09. This represents a change of 52.03% compared to the average of 39.52 of the last 4 quarters.
The mean historical PE Ratio of Orient Pharma Co., Ltd. over the last ten years is 13.67. The current 60.09 PE Ratio has changed 43.84% with respect to the historical average. Over the past ten years (40 quarters), 4166.TWO's PE Ratio was at its highest in in the June 2023 quarter at 13.74K. The PE Ratio was at its lowest in in the September 2022 quarter at -40.66.
Average
13.67
Median
-12.80
Minimum
-135.58
Maximum
202.14
Discovering the peaks and valleys of Orient Pharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 302.27%
Maximum Annual PE Ratio = 202.14
Minimum Annual Increase = -249.10%
Minimum Annual PE Ratio = -135.58
Year | PE Ratio | Change |
---|---|---|
2024 | 74.78 | -63.01% |
2023 | 202.14 | -249.10% |
2022 | -135.58 | 302.27% |
2021 | -33.70 | 134.34% |
2020 | -14.38 | 28.23% |
The current PE Ratio of Orient Pharma Co., Ltd. (4166.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
47.11
5-year avg
18.65
10-year avg
13.67
Orient Pharma Co., Ltd.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orient Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orient Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Orient Pharma Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Orient Pharma Co., Ltd. (4166.TWO)?
What is the highest PE Ratio for Orient Pharma Co., Ltd. (4166.TWO)?
What is the 3-year average PE Ratio for Orient Pharma Co., Ltd. (4166.TWO)?
What is the 5-year average PE Ratio for Orient Pharma Co., Ltd. (4166.TWO)?
How does the current PE Ratio for Orient Pharma Co., Ltd. (4166.TWO) compare to its historical average?